Investigación cardio-renal de la ERA-EDTA y la European Society of Cardiology
La prevalencia de enfermedad cardiovascular en pacientes con enfermedad renal crónica está bien establecida. Más de la mitad de todos los pacientes con insuficiencia cardíaca tienen enfermedad renal crónica moderada o severa. Ambas afecciones son susceptibles a los mismos factores de riesgo, que incluyen diabetes, hipertensión, edad e historial médico familiar. Estos factores de riesgo compartidos pueden ser la causa de la relación entre enfermedad renal y cardíaca, y durante mucho tiempo se ha asumido que las causas compartidas claves (diabetes e hipertensiòn arterial) son las responsables.
Esta colección de papers ofrecidos, destaca una selección de las últimas investigaciones sobre temas cardio-renales y su tratamiento publicados tanto por las revistas de la Asociación Renal Europea - Asociación Europea de Diálisis y Trasplante (ERA-EDTA) y la Sociedad Europea de Cardiología (ESC).
Todos los artículos listados mas abajo, se han puesto a disposición libremente hasta el 1 de septiembre de 2019, o se han publicado en acceso abierto:
Long-term cardiovascular changes following creation of arteriovenous fistula in patients with end stage renal disease
Yogesh N. V. Reddy, Masaru Obokata, Patrick G. Dean, et al.
European Heart Journal
Randomized multicentre pilot study of sacubitril/valsartan versus irbesartan in patients with chronic kidney disease: United Kingdom Heart and Renal Protection (HARP)- III—rationale, trial design and baseline data
UK HARP-III Collaborative Group
Nephrology Dialysis Transplantation
Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis
Csaba P Kovesdy, Kunihiro Matsushita, Yingying Sang, et al.
European Heart Journal
Iron therapy in heart failure patients without anaemia: possible implications for chronic kidney disease patients
Jolanta Malyszko, Stefan D Anker
Clinical Kidney Journal
Cardiovascular outcome trials in patients with chronic kidney disease: challenges associated with selection of patients and endpoints
Patrick Rossignol, Rajiv Agarwal, Bernard Canaud, et al.
European Heart Journal
Vitamin D deficiency is associated with mortality in maintenance dialysis: moving forward from epidemiology to clinical trials
Justine Bacchetta, Solenne Pelletier
Nephrology Dialysis Transplantation
Cause of kidney disease and cardiovascular events in a national cohort of US patients with end-stage renal disease on dialysis: a retrospective analysis
Michelle M O’Shaughnessy, Sai Liu, Maria E Montez-Rath, et al.
European Heart Journal
Klotho and endocrine fibroblast growth factors: marker of chronic kidney disease progression and cardiovascular complications?
Makoto Kuro-o
Nephrology Dialysis Transplantation
The microcirculation: a key player in obesity-associated cardiovascular disease
Oana Sorop, T. Dylan Olver, Jens van de Wouw, et al.
Cardiovascular Research
The impact of haemodialysis arteriovenous fistula on haemodynamic parameters of the cardiovascular system
Carlo Basile, Luigi Vernaglione, Francesco Casucci, et al.
Clinical Kidney Journal
Augmentation of phosphate-induced osteo-/chondrogenic transformation of vascular smooth muscle cells by homoarginine
Ioana Alesutan, Martina Feger, Rashad Tuffaha, et al.
Cardiovascular Research
Efficacy of a remote web-based lung ultrasound training for nephrologists and cardiologists: a LUST trial sub-project
Luna Gargani, Rosa Sicari, Mauro Raciti, et al.
Nephrology Dialysis Transplantation
Management of atrial fibrillation in patients with chronic kidney disease in Europe Results of the European Heart Rhythm Association Survey
Tatjana S. Potpara, Radoslaw Lenarczyk, Torben B. Larsen, et al.
EP Europace
FGF23 is induced by activated renin-angiotensin-aldosterone system in cardiac myocytes and promotes the pro-fibrotic crosstalk between cardiac myocytes and fibroblasts
Maren Leifheit-Nestler, Felix Kirchhoff, Julia Nespor, et al.
Nephrology Dialysis Transplantation
Relation of renal dysfunction with incident atrial fibrillation and cardiovascular morbidity and mortality: The PREVEND study
Ernaldo G Marcos, Bastiaan Geelhoed, Pim Van Der Harst,et al.
EP Europace
A clinical-genetic approach to assessing cardiovascular risk in patients with CKD
Emilio Rodrigo, Sara Pich, Isaac Subirana, et al.
Clinical Kidney Journal
Procedural outcomes and long-term survival following trans-venous defibrillator lead extraction in patients with end-stage renal disease
Anand D Shah, Lakshmi P Peddareddy, Maher A Addish, et al.
EP Europace
Cardiovascular-renal complications and the possible role of plasminogen activator inhibitor: a review
John A. D'Elia, George Bayliss, Ray E. Gleason, Larry A. Weinrauch
Clinical Kidney Journal
Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular
Giuseppe M C Rosano, Juan Tamargo, Keld P Kjeldsen, et al.
European Heart Journal- Cardiovascular Pharmacotherapy
Hypertension and cardiac arrhythmias: executive summary of a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)
Gregory Y H Lip, Antonio Coca, Thomas Kahan, et al.
European Heart Journal- Cardiovascular Pharmacotherapy
Early and asymptomatic cardiac dysfunction in chronic kidney disease
Shanmugakumar Chinnappa, Edward White, Nigel Lewis,et al.
Nephrology Dialysis Transplantation
Impact of creatinine clearance on outcomes in patients with non-valvular atrial fibrillation: a subanalysis of the J-RHYTHM Registry
Eitaro Kodani, Hirotsugu Atarashi, Hiroshi Inoue,et al.
European Heart Journal- Quality of Care & Clinical Outcomes
Vitamin D treatment attenuates cardiac FGF23/FGFR4 signaling and hypertrophy in uremic rats
Maren Leifheit-Nestler, Alexander Grabner, Laura Hermann,et al.
Nephrology Dialysis Transplantation
Association of acute kidney injury and chronic kidney disease with processes of care and long-term outcomes in patients with acute myocardial infarction
Purav Mody, Tracy Wang, Robert McNamara, et al.
European Heart Journal- Quality of Care & Clinical Outcomes
Plasma microRNA-21 for the early prediction of acute kidney injury in patients undergoing major cardiac surgery
Luise Gaede, Christoph Liebetrau, Johannes Blumenstein, et al.
Nephrology Dialysis Transplantation
Incremental value of right heart metrics and exercise performance to well-validated risk scores in dilated cardiomyopathy
Kegan J Moneghetti, Genevieve Giraldeau, Matthew T Wheeler, et al.
European Heart Journal- Cardiovascular Imaging
Angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use and cardiovascular outcomes in patients initiating peritoneal dialysis
Jenny I. Shen, Anjali B. Saxena, Maria E. Montez-Rath, et al.
Nephrology Dialysis Transplantation
Renal function decline predicted by left atrial expansion index in non-diabetic cohort with preserved systolic heart function
Shih-Hung Hsiao, Kuan-Rau Chiou
European Heart Journal- Cardiovascular Imaging
Regulation of miR-29b and miR-30c by vitamin D receptor activators contributes to attenuate uraemia-induced cardiac fibrosis
Sara Panizo, Natalia Carrillo-López, Manuel Naves-Díaz, et al.
Nephrology Dialysis Transplantation
Dr. Eduardo Lorca
